Log in
Log in
Or log in with
GoogleGoogle
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Beth Levine
Age : 58
Country of residence : Unknown
Linked companies : Regeneron Pharmaceuticals, Inc.

Biography of Beth Levine 
Beth F. Levine is Chief Compliance Officer & Senior Vice President at Regeneron Pharmaceuticals, Inc. Ms. Levine previously occupied the position of General Counsel-US Pharmaceuticals Division at Pfizer Inc., Litigation Associate at Paul, Weiss, Rifkind, Wharton & Garrison LLP and Secretary, Chief Compliance Officer & Senior VP at Keryx Biopharmaceuticals, Inc. She received an undergraduate degree from Cornell University and a graduate degree from Fordham University School of Law.


Current positions of Beth Levine 
Beth Levine : Personal Network 
Most Read News 
11/28Buffett's Berkshire countersues billionaire Haslams in battle over Pilot valuation
RE
11/28Charlie Munger, the 'Oracle of Pasadena' who was Buffett's second-in-command
RE
11/30Tesla to deliver Cybertrucks after Musk tempers expectations
MR
11/27Elon Musk, Netanyahu tour ruins of Israeli kibbutz
RE
11/22LVMH heir Antoine Arnault to step back from Berluti management role
RE
11/28Berkshire Hathaway vice chairman Charlie Munger dies at 99
RE
11/22Factbox-LVMH roles held by Bernard Arnault's children
RE
11/26Germany's Kuehne examines offer for Signa's Hamburg skyscraper -report
RE
11/30BP's search for new CEO to extend into next year as Looney probe drags on
RE
11/28Elon Musk promises to wear symbol of Gaza hostages
RE
More news


© 2023 People and Ownership :   
Beth Levine : Connections 


Latest news about Beth Levine 
2021Transcript : Regeneron Pharmaceuticals, Inc., Q1 2021 Earnings Call, May 06, 2021
CI
2019Transcript : Regeneron Pharmaceuticals, Inc. - Shareholder/Analyst Call
CI
2018Transcript : Regeneron Pharmaceuticals, Inc. - Shareholder/Analyst Call
CI
2015Ron Levine Joins Technology Applications International Corporation's Advisory Board
CI
More news

As early as today, start finding the best investment opportunities!Optimize my profits
Optimize my profits